Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02602587Completed
Open-label trial (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Difference of dendrogenin A between patients and healthy donors at Day 1. Started Nov 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02602587.